These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15504291)

  • 1. [The effect of angiotensin II type 1 receptor blocker valsartan in preventing hepatic fibrosis induced by dimethylnitrosamine in rats].
    Shen FJ; Zhu YK; Jia JD; Ma H; Wang BE
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):605-8. PubMed ID: 15504291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of perindopril and valsartan on expression of transforming growth factor-beta-Smads in experimental hepatic fibrosis in rats.
    Xu W; Song S; Huang Y; Gong Z
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1250-6. PubMed ID: 16872305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of perindopril and valsartan on the expression of TGF beta 1 and TGF beta receptor II mRNA, Smad3 and Smad7 in experimental hepatic fibrotic rats].
    Gong ZJ; Song SL; Huang YQ; Ruan P
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):737-40. PubMed ID: 15619341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic evolution of MMP-13, TIMP-1, type I and III collagen and their interaction in experimental liver fibrosis].
    Zhu YK; Wang BE; Shen FJ; Wang AM; Jia JD; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2004 Oct; 12(10):612-5. PubMed ID: 15504294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of reversion of myocardial interstitial fibrosis in diabetic cardiomyopathy by valsartan].
    Zhong M; Zhang Y; Miao Y; Li L; Gong HP; Ma X; Sun H; Zhang W
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(4):232-6. PubMed ID: 16677501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inhibitory effects of silymarin on hepatic fibrosis induced by dimethylnitrosamine: experiment with rats].
    Zhao XY; Wang BE; Wang TL; Li XM
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2563-6. PubMed ID: 17198567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II type 1 receptor blocker, valsartan, prevented cardiac fibrosis in rat cardiomyopathy after autoimmune myocarditis.
    Tachikawa H; Kodama M; Hui L; Yoshida T; Hayashi M; Abe S; Kashimura T; Kato K; Hanawa H; Watanabe K; Nakazawa M; Aizawa Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S105-10. PubMed ID: 12688405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activation of transforming growth factor-beta1/Smads signal pathway in diabetic cardiomyopathy and effects of valsartan thereon: experiment with rats].
    Miao Y; Zhang W; Zhong M; Ma X; Qi TG; Sun H
    Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):366-70. PubMed ID: 17456374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism for blockade of angiotensin subtype 1 receptors to lower plasma glucose in streptozotocin-induced diabetic rats.
    Chan P; Liu IM; Tzeng TF; Yang TL; Cheng JT
    Diabetes Obes Metab; 2007 Jan; 9(1):39-49. PubMed ID: 17199717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of combined AT1 receptor antagonist/NEP inhibitor on vascular remodeling and cardiac fibrosis in SHRSP.
    Pu Q; Brassard P; Javeshghani DM; Iglarz M; Webb RL; Amiri F; Schiffrin EL
    J Hypertens; 2008 Feb; 26(2):322-33. PubMed ID: 18192847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of angiotensin converting enzyme and angiotensin II receptor in rabbits with hyperthyroid cardiomyopathy].
    Zhang A; Deng W; Yin YH
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):712-6. PubMed ID: 18093424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The experimental study of captopril and valsartan on the preventing and treatment of diabetic retinopathy in diabetic mice].
    Xie XW; Zhao P
    Zhonghua Yan Ke Za Zhi; 2004 Nov; 40(11):770-3. PubMed ID: 15634486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bicyclol on dimethylnitrosamine-induced liver fibrosis in mice and its mechanism of action.
    Hu QW; Liu GT
    Life Sci; 2006 Jul; 79(6):606-12. PubMed ID: 16603200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of valsartan on the pathological progression of hepatic fibrosis in rats with type 2 diabetes.
    Qiang G; Zhang L; Yang X; Xuan Q; Shi L; Zhang H; Chen B; Li X; Zu M; Zhou D; Guo J; Yang H; Du G
    Eur J Pharmacol; 2012 Jun; 685(1-3):156-64. PubMed ID: 22546234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of idoxifene on hepatic fibrosis in rats.
    Zhou YJ; Yin DM; Chen HS; Shi JH; Sha BX; Wang X
    Acta Pharmacol Sin; 2005 May; 26(5):581-6. PubMed ID: 15842777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dynamic evolution of MMP-2 gene expression and its enzymatic activities in experimental liver fibrosis].
    Zhu YK; Wang BE; Shen FJ; Jia JD; Ma H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jul; 13(7):509-12. PubMed ID: 16042886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.
    Miyajima K; Minatoguchi S; Ito Y; Hukunishi M; Matsuno Y; Kakami M; Kawasaki M; Nishigaki K; Takemura G; Fujiwara H
    Hypertens Res; 2007 Apr; 30(4):307-13. PubMed ID: 17541209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC; Chiu YT; Cheng CC; Wu CF; Lin YL; Huang YT
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flavonoid quercetin inhibits dimethylnitrosamine-induced liver damage in rats.
    Lee ES; Lee HE; Shin JY; Yoon S; Moon JO
    J Pharm Pharmacol; 2003 Aug; 55(8):1169-74. PubMed ID: 12956909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.